KLRK1 and neoplasm: CD8 T cells from TCF-1 cKO and WT mice were then cultured with tumor target A20 cells [47] in a 40:1 ratio of tumor cells to CD8 T cells, along with anti-NKG2D antibody or isotype control antibody for 4 h.